OVID earnings
Ovid Therapeutics (OVID) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
OVID earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | -0.08 | -0.12 | 30.43% | $733.00K |
| Q1 2026 | May 12, 2026 | -0.12 | -0.12 | 0.00% | – |
| Q4 2025 | Mar 18, 2026 | 0.06 | -0.10 | 160.00% | $718.00K |
| Q3 2025 | Nov 12, 2025 | -0.17 | -0.15 | -13.33% | $132.00K |
| Q2 2025 | Aug 13, 2025 | -0.06 | -0.16 | 62.50% | $6.27M |
| Q1 2025 | May 13, 2025 | -0.14 | -0.14 | 0.00% | $130.00K |
| Q4 2024 | Mar 11, 2025 | -0.13 | -0.16 | 18.75% | $76.00K |
| Q3 2024 | Nov 12, 2024 | -0.20 | -0.19 | -5.26% | $173.00K |
| Q2 2024 | Aug 13, 2024 | 0.12 | -0.22 | 154.55% | $169.00K |
| Q1 2024 | May 14, 2024 | -0.17 | -0.23 | 26.09% | $148.00K |
| Q4 2023 | Mar 8, 2024 | -0.22 | -0.17 | -29.41% | $142.00K |
| Q3 2023 | Nov 3, 2023 | -0.16 | -0.18 | 11.11% | $109.00K |
| Aug 4, 2023 | -0.18 | -0.21 | 14.29% | – | |
| May 5, 2023 | -0.19 | -0.18 | -5.56% | – | |
| Mar 13, 2023 | -0.16 | -0.19 | 15.79% | – | |
| Nov 8, 2022 | -0.17 | -0.21 | 19.05% | – | |
| Aug 9, 2022 | -0.21 | -0.23 | 8.70% | – | |
| May 10, 2022 | -0.23 | 1.17 | -119.66% | – | |
| Mar 15, 2022 | -0.38 | -0.17 | -123.53% | – | |
| Nov 10, 2021 | -0.17 | -0.19 | 10.53% | – |
- OVID reports next on Nov 11, 2026, with EPS of -0.09 expected.
- OVID beat EPS estimates in 23 of its last 38 reports.
Updated 2026-11-07 11:53 UTC